Towards Healthcare
Cell Harvesting Market Size 2025 is Valued at USD 6.71 Billion

Cell Harvesting Market 2025 Surge in Cell and Gene Therapies and AI Integration Driving Future Growth

Market insights predict the global cell harvesting industry will increase from USD 5.94 billion in 2024 to USD 20.08 billion by 2034, achieving a CAGR of 12.95%. The cell harvesting market is expanding due to rising demand for cell and gene therapies as well as growing use of stem cell-based treatment approaches. North America led the market due to the presence of a robust industrial infrastructure.

Content

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The cell harvesting market is projected to reach USD 20.08 billion by 2034, growing at a CAGR of 12.95% from 2024 to 2034.

North America is currently leading the cell harvesting market due to the presence of a robust Industrial Infrastructure.

The cell harvesting market includes 6 segments such as by product type,Shape, Picture by cell type, Shape, Pictureby application, Shape, Picture by technique, Shape, Picture by end user, and by region.

Some key players include Thermo Fisher Scientific Inc., Merck KGaA (MilliporeSigma), GE HealthCare (Cytiva), and Sartorius AG.

Key trends include innovation in recombinant 9-valent HPV vaccine and growth in cell and gene therapies.

Isolation of target cells from the growth medium is known as cell harvesting.

Cell harvesting can be used for regenerative medicine, cell & gene therapy, cancer research, and diagnostic applications.

American Society of Gene & Cell Therapy (ASGCT), Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions